Their associated antibodies were anti-Recoverin with T cell lymphoma, multiple antibodies (anti-Yo, anti-ZIC4, anti-NMDAR) with TCC, and anti-GAD65 with leukemia. Here, CDR2 is linked to T-cell non-Hodgkin lymphoma.